PODD
Insulet Corporation (PODD)
Healthcare • NASDAQ • $148.16+0.88%
- Symbol
- PODD
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $148.16
- Daily Change
- +0.88%
- Market Cap
- $9.94B
- Trailing P/E
- 26.89
- Forward P/E
- 18.59
- 52W High
- $354.88
- 52W Low
- $126.40
- Analyst Target
- $171.91
- Dividend Yield
- N/A
- Beta
- 1.09
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the ri…
Company websiteResearch PODD on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.